Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies.

Bae SH, Kim MS, Cho CK, Kang JK, Lee SY, Lee KN, Lee DH, Han CJ, Yang KY, Kim SB.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e469-74. doi: 10.1016/j.ijrobp.2012.06.005.

PMID:
23078899
2.

Severe intestinal toxicity after stereotactic ablative radiotherapy for abdominopelvic malignancies.

Bae SH, Kim MS, Kim SY, Jang WI, Cho CK, Yoo HJ, Kim KB, Lee DH, Han CJ, Yang KY, Kim SB.

Int J Colorectal Dis. 2013 Dec;28(12):1707-13. doi: 10.1007/s00384-013-1717-6. Epub 2013 Jun 18.

PMID:
23775098
3.

Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy.

Nakamura A, Shibuya K, Matsuo Y, Nakamura M, Shiinoki T, Mizowaki T, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):369-75. doi: 10.1016/j.ijrobp.2011.12.026. Epub 2012 Feb 28.

PMID:
22381898
4.

Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.

Barney BM, Olivier KR, Macdonald OK, Fong de Los Santos LE, Miller RC, Haddock MG.

Am J Clin Oncol. 2012 Dec;35(6):537-42. doi: 10.1097/COC.0b013e31821f876a.

PMID:
21659830
5.

Dosimetric analysis of organs at risk during expiratory gating in stereotactic body radiation therapy for pancreatic cancer.

Taniguchi CM, Murphy JD, Eclov N, Atwood TF, Kielar KN, Christman-Skieller C, Mok E, Xing L, Koong AC, Chang DT.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1090-5. doi: 10.1016/j.ijrobp.2012.07.2366. Epub 2012 Dec 27.

PMID:
23273994
6.

Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma.

Yoon H, Oh D, Park HC, Kang SW, Han Y, Lim DH, Paik SW.

Strahlenther Onkol. 2013 Jul;189(7):541-6. doi: 10.1007/s00066-013-0343-0. Epub 2013 May 25.

PMID:
23703401
7.

Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).

Stephans KL, Djemil T, Tendulkar RD, Robinson CG, Reddy CA, Videtic GM.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):974-80. doi: 10.1016/j.ijrobp.2010.12.002. Epub 2011 Feb 6.

PMID:
21300453
8.

A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.

Barriger RB, Forquer JA, Brabham JG, Andolino DL, Shapiro RH, Henderson MA, Johnstone PA, Fakiris AJ.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):457-62. doi: 10.1016/j.ijrobp.2010.08.056. Epub 2010 Oct 29.

PMID:
21035956
9.

Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response.

Jabbari S, Weinberg VK, Kaprealian T, Hsu IC, Ma L, Chuang C, Descovich M, Shiao S, Shinohara K, Roach M 3rd, Gottschalk AR.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):228-34. doi: 10.1016/j.ijrobp.2010.10.026. Epub 2010 Dec 22.

PMID:
21183287
10.

Predictors of radiotherapy induced bone injury (RIBI) after stereotactic lung radiotherapy.

Taremi M, Hope A, Lindsay P, Dahele M, Fung S, Purdie TG, Jaffray D, Dawson L, Bezjak A.

Radiat Oncol. 2012 Sep 17;7:159. doi: 10.1186/1748-717X-7-159.

11.

Dose--volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer.

Matsuo Y, Shibuya K, Nakamura M, Narabayashi M, Sakanaka K, Ueki N, Miyagi K, Norihisa Y, Mizowaki T, Nagata Y, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e545-9. doi: 10.1016/j.ijrobp.2012.01.018. Epub 2012 Mar 19.

PMID:
22436782
12.

Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.

Asai K, Shioyama Y, Nakamura K, Sasaki T, Ohga S, Nonoshita T, Yoshitake T, Ohnishi K, Terashima K, Matsumoto K, Hirata H, Honda H.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):768-73. doi: 10.1016/j.ijrobp.2012.01.027. Epub 2012 Mar 23.

PMID:
22445398
13.

Vertebral compression fracture (VCF) after spine stereotactic body radiation therapy (SBRT): analysis of predictive factors.

Cunha MV, Al-Omair A, Atenafu EG, Masucci GL, Letourneau D, Korol R, Yu E, Howard P, Lochray F, da Costa LB, Fehlings MG, Sahgal A.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e343-9. doi: 10.1016/j.ijrobp.2012.04.034. Epub 2012 Jun 1.

PMID:
22658511
14.

Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.

Stephans KL, Djemil T, Diaconu C, Reddy CA, Xia P, Woody NM, Greskovich J, Makkar V, Videtic GM.

Int J Radiat Oncol Biol Phys. 2014 Sep 1;90(1):197-202. doi: 10.1016/j.ijrobp.2014.05.011. Epub 2014 Jul 8.

PMID:
25015204
15.

Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.

Eriguchi T, Takeda A, Sanuki N, Oku Y, Aoki Y, Shigematsu N, Kunieda E.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1006-11. doi: 10.1016/j.ijrobp.2012.09.012. Epub 2012 Oct 23.

PMID:
23102838
16.

Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases.

Koyfman SA, Djemil T, Burdick MJ, Woody N, Balagamwala EH, Reddy CA, Angelov L, Suh JH, Chao ST.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):297-302. doi: 10.1016/j.ijrobp.2011.05.067. Epub 2011 Oct 8.

PMID:
21985940
17.

Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.

Mutter RW, Liu F, Abreu A, Yorke E, Jackson A, Rosenzweig KE.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1783-90. doi: 10.1016/j.ijrobp.2011.03.053. Epub 2011 Aug 23.

18.

Predictive factors of gastroduodenal toxicity in cirrhotic patients after three-dimensional conformal radiotherapy for hepatocellular carcinoma.

Kim H, Lim do H, Paik SW, Yoo BC, Koh KG, Lee JH, Choi MS, Park W, Park HC, Huh SJ, Choi DH, Ahn YC.

Radiother Oncol. 2009 Nov;93(2):302-6. doi: 10.1016/j.radonc.2009.05.017. Epub 2009 Jun 11.

PMID:
19524314
19.

A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer.

Murphy JD, Christman-Skieller C, Kim J, Dieterich S, Chang DT, Koong AC.

Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1420-6. doi: 10.1016/j.ijrobp.2009.09.075. Epub 2010 Apr 14.

PMID:
20399033
20.

Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.

Bignardi M, Cozzi L, Fogliata A, Lattuada P, Mancosu P, Navarria P, Urso G, Vigorito S, Scorsetti M.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1570-7. doi: 10.1016/j.ijrobp.2009.05.035. Epub 2009 Oct 31.

PMID:
19880261
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk